ClinicalMetric / Countries / Netherlands / cervical cancer
← 🇳🇱 Netherlands Trials
🇳🇱 Netherlands Country × Condition

cervical cancer Clinical Trials in Netherlands

Active clinical trials for cervical cancer with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands

Active Trials in Netherlands (3)

NCT04475354
Recruiting

Distress In CErvical Cancer Patients and Partners

Enrollment
832 pts
Country
🇳🇱 Netherlands
Comprehensive Cancer Centre The Net...
View Trial →
NCT07645625 Phase 4
Recruiting

Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

Enrollment
261 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial →
NCT05062707
Recruiting

Early Ageing During Therapy in AYA Cancer Patients

Enrollment
120 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial →

Frequently Asked Questions

How many cervical cancer clinical trials are active in Netherlands?
There are currently 3 active clinical trials for cervical cancer with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a cervical cancer clinical trial in Netherlands?
To join a cervical cancer clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are cervical cancer trials in Netherlands?
Active cervical cancer trials in Netherlands span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Netherlands Trials → Global cervical cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology